PARP3 controls TGFβ and ROS driven epithelial-to-mesenchymal transition and stemness by stimulating a

Olga Karicheva1, José Manuel Rodriguez-Vargas1, Nadège Wadier1

  • 1Poly(ADP-ribosyl)ation and Genome Integrity, Laboratoire d'Excellence Medalis, UMR7242, Centre National de la Recherche Scientifique/Université de Strasbourg, Institut de Recherche de l'Ecole de Biotechnologie de Strasbourg, 67412 Illkirch, France.

Oncotarget
|September 1, 2016
PubMed

Insights

Poly(ADP-ribose) polymerase 3 (PARP3) is crucial for epithelial-to-mesenchymal transition (EMT) and stem-like properties in breast cancer cells. PARP3 promotes EMT by regulating key molecular axes and enhances cancer stem cell characteristics.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Cell Biology

Background:

  • Poly(ADP-ribose) polymerase (PARP) family members are key in genome integrity and cancer drug development.
  • PARP3 is known for its roles in DNA repair and mitosis.
  • The function of PARP3 in epithelial-to-mesenchymal transition (EMT) and stemness remains largely unexplored.

Purpose of the Study:

  • To investigate the role of PARP3 in TGFβ and reactive oxygen species (ROS)-induced EMT.
  • To determine PARP3's involvement in the development of stem-like cell properties in breast cancer.
  • To explore the therapeutic potential of targeting PARP3 in cancer.

Main Methods:

  • Analysis of PARP3 expression in breast cancer cell lines with different phenotypes.
  • Induction of EMT using TGFβ and assessment of PARP3 expression.
  • Depletion of PARP3 using siRNA and evaluation of EMT markers and processes.
  • Assessment of stem-like cell properties, including marker expression and spheroid formation.

Main Results:

  • PARP3 expression is elevated in mesenchymal breast cancer cells and inversely correlates with E-cadherin, positively with Vimentin.
  • PARP3 is upregulated during TGFβ-induced EMT and is essential for TGFβ-dependent EMT progression.
  • PARP3 depletion inhibits EMT by affecting the Snail-E-cadherin axis, cell junctions, motility, and chemoresistance.
  • PARP3 promotes stem-like properties by upregulating SOX2 and OCT4, increasing CD44high/CD24low population, and enhancing spheroid formation.

Conclusions:

  • PARP3 plays a significant role in regulating TGFβ-induced EMT and stem-like cell characteristics in mammary epithelial and breast cancer cells.
  • PARP3 acts through a TG2-Snail-E-cadherin axis, modulated by ROS, during EMT.
  • These findings highlight PARP3 as a novel therapeutic target for inhibiting EMT and cancer stemness.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.8K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.1K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
38.8K
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
7.4K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K